had experienced at least one drug shortage in the past six months and nearly half experienced 21 or more shortages
With a multifaceted approach, Pharmagen, Inc. is meeting the demands of the health provider market through dynamic, independent wholesale, compounding/admix, and innovative IT solutions. Nationally focused, we are a distributor of specialty drugs, FDA registered 503B Sterile outsourced facility, and a producer of over-the-counter (OTC) branded multivitamins. The Food and Drug Administration continues to see an increasing number of shortages, especially those involving sterile injectable drugs. We currently function as a total solution provider to hospitals, offering both sterile compounding/admix pharmacy and a just-in-time supply of products that are hard to find due to drug manufacturers’ production shortages. Leveraging our understanding of drug shortages, our long term goal is to become an FDA approved manufacturer of habitually short supply, sterile pharmaceuticals. Through an industry changing, cGMP + ® process, employing single-use, modular systems, we intend to be the gold standard of sterile production in the United States.
In addition to pharmaceuticals, we manufacture and distribute over-the-counter (OTC) branded health supplements. Our innovative approach to OTC is to create suites of products designed to work in conjunction with prescription medications to alleviate side effects and/or prevent drug interactions. With an aging population, more Americans than ever rely on prescription medications, and dangerous drug interactions are a growing problem. We are currently analyzing several OTC products that would allow us to become a powerful player in the multi-billion-dollar health supplement market.
Stock Symbol: PHRX